HIF-1 inhibitors (MerLion/NCI)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHIF-1 inhibitors (MerLion/NCI)
Drug Alias Namedeacetylravidomycinhypoxia inducible factor 1 inhibitors (National Cancer Institute/MerLion)virenomycin VN-885NSC-354844
ClassificationSmall molecules
Mechanisms of ActionHypoxia-inducible factor 1 inhibitorsBioreducible cytotoxin
TargetsHypoxia-inducible factor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingapore
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerlion Pharmaceuticals Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerlion Pharmaceuticals GmbhNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A